{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Kim KH"],"funding":["Korea Health Industry Development Institute","National Research Foundation of Korea"],"pagination":["16860"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC6237877"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["8(1)"],"pubmed_abstract":["Idiopathic pulmonary fibrosis (IPF) is a devastating and common chronic lung disease pathologically characterized by loss of epithelial cells and activation of fibroblasts and myofibroblasts. The etiology of IPF remains unclear and the disease pathology is poorly understood with no known efficacious therapy. PM014 is an herbal extract that has been shown to have beneficial effects in pulmonary diseases, which are likely to exert anti-inflammatory bioactions. In the present study, we observed that bleomycin (BLM) caused increased inflammatory infiltration as well as collagen deposition in lungs of mice on day 14 after treatment. Administration of PM014 suppressed BLM-induced inflammatory responses and fibrotic changes in dose-dependent manner in mice. Additionally, we provided in vitro evid"],"journal":["Scientific reports"],"pubmed_title":["A standardized herbal extract PM014 ameliorates pulmonary fibrosis by suppressing the TGF-β1 pathway."],"pmcid":["PMC6237877"],"funding_grant_id":["NRF-2017R1A2B3009574","HI15C0214"],"pubmed_authors":["Lee S","Bae H","Shin D","Kim HW","Min D","Lee H","Kim KH","Ryu B","Kim M"],"additional_accession":[]},"is_claimable":false,"name":"A standardized herbal extract PM014 ameliorates pulmonary fibrosis by suppressing the TGF-β1 pathway.","description":"Idiopathic pulmonary fibrosis (IPF) is a devastating and common chronic lung disease pathologically characterized by loss of epithelial cells and activation of fibroblasts and myofibroblasts. The etiology of IPF remains unclear and the disease pathology is poorly understood with no known efficacious therapy. PM014 is an herbal extract that has been shown to have beneficial effects in pulmonary diseases, which are likely to exert anti-inflammatory bioactions. In the present study, we observed that bleomycin (BLM) caused increased inflammatory infiltration as well as collagen deposition in lungs of mice on day 14 after treatment. Administration of PM014 suppressed BLM-induced inflammatory responses and fibrotic changes in dose-dependent manner in mice. Additionally, we provided in vitro evid","dates":{"release":"2018-01-01T00:00:00Z","publication":"2018 Nov","modification":"2026-07-16T11:35:40.07Z","creation":"2019-03-27T00:08:48Z"},"accession":"S-EPMC6237877","cross_references":{"pubmed":["30443024"],"doi":["10.1038/s41598-018-35320-8"]}}